Skip to main content
. 2000 Jun 6;97(12):6797–6802. doi: 10.1073/pnas.97.12.6797

Table 1.

HIV-1 JR-CSF infectability of PBMCs from HIV-2-infected individuals

Patient identification no. Peak p24, pg/ml Positive years CD4+ Phenotype
2602   10 4 744 R
2   13 5 483 R
1082   33 9 184 R
31   58 7 458 R
2269   131 5 689 R
342   230 11 603 R
1704   374 6 1,027 R
879   571 9 ND R
636   619 5 1,285 R
1503   830 5 1,089 R
1972  1,520 <1 1,182 R
2712  1,936 5 577 R
1079  3,462 3 1,030 R
82  4,889 11 1,647 R
22  9,984 8 899 S
337  35,883 6 522 S
912  49,032 11 671 S
2378  55,600 4 1,162 S
2028  60,117 9 1,475 S
1960  85,200 6 728 S
2822 101,911 4 ND S
3199 103,439 2 ND S
996 122,065 7 611 S
1814 146,433 10 1,095 S
2661 176,815 5 1,198 S
524 198,968 11 1,451 S
288 643,919 9 905 S
1130 647,340 8 854 S

Positive years, difference between sample year and infection date (when known) or date of the first positive bleed. CD4+, CD4+ cell counts within 1 year of sample collection. ND, not determined; R, resistance (peak p24 levels <5,000 pg/ml); S, susceptibility.